TY - JOUR
T1 - Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016
T2 - a systematic analysis for the Global Burden of Disease Study 2016
AU - GBD 2016 Lower Respiratory Infections Collaborators
AU - Troeger, Christopher
AU - Blacker, Brigette
AU - Khalil, Ibrahim A.
AU - Rao, Puja C.
AU - Cao, Jackie
AU - Zimsen, Stephanie R.M.
AU - Albertson, Samuel B.
AU - Deshpande, Aniruddha
AU - Farag, Tamer
AU - Abebe, Zegeye
AU - Adetifa, Ifedayo Morayo O.
AU - Adhikari, Tara Ballav
AU - Akibu, Mohammed
AU - Al Lami, Faris Hasan
AU - Al-Eyadhy, Ayman
AU - Alvis-Guzman, Nelson
AU - Amare, Azmeraw T.
AU - Amoako, Yaw Ampem
AU - Antonio, Carl Abelardo T.
AU - Aremu, Olatunde
AU - Asfaw, Ephrem Tsegay
AU - Asgedom, Solomon Weldegebreal
AU - Atey, Tesfay Mehari
AU - Attia, Engi Farouk
AU - Avokpaho, Euripide Frinel G.Arthur
AU - Ayele, Henok Tadesse
AU - Ayuk, Tambe Betrand
AU - Balakrishnan, Kalpana
AU - Barac, Aleksandra
AU - Bassat, Quique
AU - Behzadifar, Masoud
AU - Behzadifar, Meysam
AU - Bhaumik, Soumyadeep
AU - Bhutta, Zulfiqar A.
AU - Bijani, Ali
AU - Brauer, Michael
AU - Brown, Alexandria
AU - Camargos, Paulo A.M.
AU - Castañeda-Orjuela, Carlos A.
AU - Colombara, Danny
AU - Conti, Sara
AU - Dadi, Abel Fekadu
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Do, Huyen Phuc
AU - Dubljanin, Eleonora
AU - Edessa, Dumessa
AU - Elkout, Hajer
AU - Endries, Aman Yesuf
AU - Fijabi, Daniel Obadare
N1 - Publisher Copyright:
© 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Background: Lower respiratory infections are a leading cause of morbidity and mortality around the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, provides an up-to-date analysis of the burden of lower respiratory infections in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 26 years and shows how the burden of lower respiratory infection has changed in people of all ages. Methods: We used three separate modelling strategies for lower respiratory infections in GBD 2016: a Bayesian hierarchical ensemble modelling platform (Cause of Death Ensemble model), which uses vital registration, verbal autopsy data, and surveillance system data to predict mortality due to lower respiratory infections; a compartmental meta-regression tool (DisMod-MR), which uses scientific literature, population representative surveys, and health-care data to predict incidence, prevalence, and mortality; and modelling of counterfactual estimates of the population attributable fraction of lower respiratory infection episodes due to Streptococcus pneumoniae, Haemophilus influenzae type b, influenza, and respiratory syncytial virus. We calculated each modelled estimate for each age, sex, year, and location. We modelled the exposure level in a population for a given risk factor using DisMod-MR and a spatio-temporal Gaussian process regression, and assessed the effectiveness of targeted interventions for each risk factor in children younger than 5 years. We also did a decomposition analysis of the change in LRI deaths from 2000–16 using the risk factors associated with LRI in GBD 2016. Findings: In 2016, lower respiratory infections caused 652 572 deaths (95% uncertainty interval [UI] 586 475–720 612) in children younger than 5 years (under-5s), 1 080 958 deaths (943 749–1 170 638) in adults older than 70 years, and 2 377 697 deaths (2 145 584–2 512 809) in people of all ages, worldwide. Streptococcus pneumoniae was the leading cause of lower respiratory infection morbidity and mortality globally, contributing to more deaths than all other aetiologies combined in 2016 (1 189 937 deaths, 95% UI 690 445–1 770 660). Childhood wasting remains the leading risk factor for lower respiratory infection mortality among children younger than 5 years, responsible for 61·4% of lower respiratory infection deaths in 2016 (95% UI 45·7–69·6). Interventions to improve wasting, household air pollution, ambient particulate matter pollution, and expanded antibiotic use could avert one under-5 death due to lower respiratory infection for every 4000 children treated in the countries with the highest lower respiratory infection burden. Interpretation: Our findings show substantial progress in the reduction of lower respiratory infection burden, but this progress has not been equal across locations, has been driven by decreases in several primary risk factors, and might require more effort among elderly adults. By highlighting regions and populations with the highest burden, and the risk factors that could have the greatest effect, funders, policy makers, and programme implementers can more effectively reduce lower respiratory infections among the world's most susceptible populations. Funding: Bill & Melinda Gates Foundation.
AB - Background: Lower respiratory infections are a leading cause of morbidity and mortality around the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, provides an up-to-date analysis of the burden of lower respiratory infections in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 26 years and shows how the burden of lower respiratory infection has changed in people of all ages. Methods: We used three separate modelling strategies for lower respiratory infections in GBD 2016: a Bayesian hierarchical ensemble modelling platform (Cause of Death Ensemble model), which uses vital registration, verbal autopsy data, and surveillance system data to predict mortality due to lower respiratory infections; a compartmental meta-regression tool (DisMod-MR), which uses scientific literature, population representative surveys, and health-care data to predict incidence, prevalence, and mortality; and modelling of counterfactual estimates of the population attributable fraction of lower respiratory infection episodes due to Streptococcus pneumoniae, Haemophilus influenzae type b, influenza, and respiratory syncytial virus. We calculated each modelled estimate for each age, sex, year, and location. We modelled the exposure level in a population for a given risk factor using DisMod-MR and a spatio-temporal Gaussian process regression, and assessed the effectiveness of targeted interventions for each risk factor in children younger than 5 years. We also did a decomposition analysis of the change in LRI deaths from 2000–16 using the risk factors associated with LRI in GBD 2016. Findings: In 2016, lower respiratory infections caused 652 572 deaths (95% uncertainty interval [UI] 586 475–720 612) in children younger than 5 years (under-5s), 1 080 958 deaths (943 749–1 170 638) in adults older than 70 years, and 2 377 697 deaths (2 145 584–2 512 809) in people of all ages, worldwide. Streptococcus pneumoniae was the leading cause of lower respiratory infection morbidity and mortality globally, contributing to more deaths than all other aetiologies combined in 2016 (1 189 937 deaths, 95% UI 690 445–1 770 660). Childhood wasting remains the leading risk factor for lower respiratory infection mortality among children younger than 5 years, responsible for 61·4% of lower respiratory infection deaths in 2016 (95% UI 45·7–69·6). Interventions to improve wasting, household air pollution, ambient particulate matter pollution, and expanded antibiotic use could avert one under-5 death due to lower respiratory infection for every 4000 children treated in the countries with the highest lower respiratory infection burden. Interpretation: Our findings show substantial progress in the reduction of lower respiratory infection burden, but this progress has not been equal across locations, has been driven by decreases in several primary risk factors, and might require more effort among elderly adults. By highlighting regions and populations with the highest burden, and the risk factors that could have the greatest effect, funders, policy makers, and programme implementers can more effectively reduce lower respiratory infections among the world's most susceptible populations. Funding: Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85056226781&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(18)30310-4
DO - 10.1016/S1473-3099(18)30310-4
M3 - Article
C2 - 30243584
AN - SCOPUS:85056226781
SN - 1473-3099
VL - 18
SP - 1191
EP - 1210
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 11
ER -